ALT Return on Tangible Equity | ALTIMMUNE, INC.

ALTIMMUNE, INC. (ALT) Return on Tangible Equity

2026-06-30: Return Tang Equity -19.87%.
2026-03-31: Return Tang Equity -33.54%.
2025-12-31: Return Tang Equity -41.46%.
2025-09-30: Return Tang Equity -48.45%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-19.87%
2026-03-31	-33.54%
2025-12-31	-41.46%
2025-09-30	-48.45%
2025-06-30	-58.91%
2025-03-31	-69.55%
2024-12-31	-85.57%
2024-09-30	-85.58%
2024-06-30	-72.33%
2024-03-31	-57.79%
2023-12-31	-48.68%
2023-09-30	-56.87%
2023-06-30	-52.36%
2023-03-31	-54.96%
2022-12-31	-49.00%
2022-09-30	-42.52%
2022-06-30	-49.98%
2022-03-31	-55.16%
2021-12-31	-48.90%
2021-09-30	-40.17%
2021-06-30	-28.28%
2021-03-31	-24.40%
2020-12-31	-21.75%
2020-09-30	-21.33%
2020-06-30	-45.09%
2020-03-31	-53.65%
2019-12-31	-45.39%
2019-09-30	-83.43%
2019-06-30	-57.88%
2019-03-31	-64.59%
2018-12-31	-81.81%
2018-09-30	-59.92%
2018-06-30	-144.49%
2018-03-31	-112.41%
2017-12-31	-156.92%
2017-09-30	-104.22%
2017-06-30	-38.77%
2017-03-31	-53.48%
2016-12-31	-82.50%
2016-09-30	-6.62%
2016-06-30	-24.69%
2016-03-31	-46.17%
2015-12-31	-16.67%
2015-09-30	-31.53%
2015-06-30	-50.89%
2015-03-31	-35.27%
2014-12-31	-62.51%
2014-09-30	-74.57%
2014-06-30	-129.97%
2014-03-31	-198.52%
2013-12-31	-234.97%
2013-09-30	-95.09%
2013-06-30	-44.44%
2013-03-31	-57.30%
2012-12-31	-52.76%
2012-09-30	-28.44%
2012-06-30	-24.30%
2012-03-31	-38.54%
2011-12-31	-28.12%
2011-09-30	-170.07%
2011-06-30	-213.45%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-41.46%
2024-12-31	-85.57%
2023-12-31	-48.68%
2022-12-31	-49.00%
2021-12-31	-48.86%
2020-12-31	-21.75%
2019-12-31	-45.39%
2018-12-31	-81.81%
2017-12-31	-230.27%
2016-12-31	-85.47%
2015-12-31	-16.67%
2014-12-31	-62.51%
2013-12-31	-234.97%
2012-12-31	-52.76%
2011-12-31	-28.12%
2010-12-31	-353.36%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82
CytomX Therapeutics, Inc. (CTMX)	United States	$0.598B	-10.25
CorMedix Inc. (CRMD)	United States	$0.605B	3.25
Aquestive Therapeutics, Inc. (AQST)	United States	$0.606B	-6.67
IMPACT BIOMEDICAL INC. (IBO)	United States	$0.611B	66.47
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
Neurogene Inc. (NGNE)		$0.625B	-4.46
Shattuck Labs, Inc. (STTK)	United States	$0.634B	-13.30
BlossomHill Therapeutics, Inc. (BLSM)	United States	$0.647B
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B